The other side of the story

The evolving landscape of COVID-19 treatments

the other side of the storyRight now, vaccines are still claiming the majority of public attention – but safe and effective treatments are a critical weapon in our battle against COVID-19, offering hope of turning a potentially fatal virus into an inherently manageable one.

Although only a few treatments have been approved for use so far, the COVID-19 therapy development space is a hive of activity, with numerous manufacturers working on repurposing existing drugs and innovating new treatments.

In this article, we explore the focus for COVID-19 treatment development, the current COVID-19 treatment landscape and, drawing on real-world data from Ipsos’ new COVID-19 Therapy Monitor, how treatments are being used in real-world clinical practice.

 

 

Download

Related news

  • [Webinar] KEYS: Battle For Attention
    Communication Events replay

    [Webinar] KEYS: Battle For Attention

    In an era dominated by ad-skipping, multi-screening, and media fragmentation, the challenge for today’s marketer is no longer just “Who am I reaching?” but “Am I reaching them at all?"
  • Where is metabolic medicine heading
    Healthcare Events replay

    Where is metabolic medicine heading – and what do you need to know?

    What happens when pipeline promise becomes market reality? During this PBSS webinar, Scott Morano and Roberto Cortese expertly guide viewers through the recent transformations in metabolic therapeutics for obesity, diabetes and MASH, and where the field is heading next.
  • KEYS: Screen time
    Media Measurement Events replay

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?